APA (7th ed.) Citation

Brandberg, Y., Johansson, H., Aamdal, S., Bastholt, L., Hernberg, M., Stierner, U., . . . Hansson, J. (2013). Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma. Acta Oncologica, 52(6), 1086. https://doi.org/10.3109/0284186X.2013.789140

Chicago Style (17th ed.) Citation

Brandberg, Yvonne, Hemming Johansson, Steinar Aamdal, Lars Bastholt, Michaela Hernberg, Ulrika Stierner, Hans von der Maase, and Johan Hansson. "Role Functioning Before Start of Adjuvant Treatment Was an Independent Prognostic Factor for Survival and Time to Failure. A Report from the Nordic Adjuvant Interferon Trial for Patients with High-risk Melanoma." Acta Oncologica 52, no. 6 (2013): 1086. https://doi.org/10.3109/0284186X.2013.789140.

MLA (9th ed.) Citation

Brandberg, Yvonne, et al. "Role Functioning Before Start of Adjuvant Treatment Was an Independent Prognostic Factor for Survival and Time to Failure. A Report from the Nordic Adjuvant Interferon Trial for Patients with High-risk Melanoma." Acta Oncologica, vol. 52, no. 6, 2013, p. 1086, https://doi.org/10.3109/0284186X.2013.789140.